Loss of miR-217 promotes osteosarcoma cell proliferation through targeting SETD8

Pharmazie. 2018 Dec 1;73(12):711-714. doi: 10.1691/ph.2018.8644.

Abstract

Recently, many kinds of microRNAs (miRNAs) have been found to play a critical role in progression of osteosarcoma (OS). miR-217 was reported to function as a tumor suppressor in a number of human cancers but its precise mechanism to exert the suppressive role remains to be investigated. In this study, we found that miR-217 was downregulated in OS tissues and its downregulation predicts poor overall survival of OS patients. Importantly, we found that a lower expressed miR-217 in OS cell lines inhibited the cell proliferation and invasion in vitro. By bioinformatic analysis, we found that miR-217 targeted the SET Domain-Containing Protein 8 (SETD8), and there was a negative correlation between them in OS tissues. Furthermore, we found that miR-217 abolished the stimulation effect of SETD8 on cell proliferation and invasion. Taken together, our data provide solid evidence that miR-217 functions as tumor suppressor in OS, and its tumor-suppressive effect is exerted through interaction with SETD8.

MeSH terms

  • Bone Neoplasms / genetics
  • Bone Neoplasms / pathology*
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Histone-Lysine N-Methyltransferase / metabolism*
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Neoplasm Invasiveness
  • Osteosarcoma / genetics
  • Osteosarcoma / pathology*
  • Survival Rate

Substances

  • MIRN217 microRNA, human
  • MicroRNAs
  • Histone-Lysine N-Methyltransferase
  • KMT5A protein, human